Walleye Trading
BIO icon

Walleye Trading’s Bio-Rad Laboratories Class A BIO Stock Holding History

Walleye Trading’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-918
Closed -$383K – 4972
2022
Q3 		$383K Buy
+918
New +$458K ﹤0.01% 3144
2022
Q2 		– Sell
-345
Closed -$194K – 5130
2022
Q1 		$194K Sell
345
-439
-56% -$265K ﹤0.01% 3819
2021
Q4 		$592K Buy
784
+277
+55% +$207K ﹤0.01% 2772
2021
Q3 		$378K Sell
507
-204
-29% -$153K ﹤0.01% 3205
2021
Q2 		$458K Buy
711
+634
+823% +$386K ﹤0.01% 3018
2021
Q1 		$44K Buy
+77
New +$45.6K ﹤0.01% 4365
2020
Q2 		– Sell
-806
Closed -$356K – 4237
2020
Q1 		$283K Buy
+806
New +$296K ﹤0.01% 2343
2019
Q4 		– Sell
-944
Closed -$333K – 4241
2019
Q3 		$314K Buy
+944
New +$308K ﹤0.01% 2543
2017
Q2 		– Sell
-4
Closed -$1K – 4495
2017
Q1 		$1K Sell
4
-5
-56% -$963 ﹤0.01% 4567
2016
Q4 		$2K Sell
9
-3
-25% -$511 ﹤0.01% 4550
2016
Q3 		$2K Buy
+12
New +$1.82K ﹤0.01% 4659
2016
Q2 		– Sell
-432
Closed -$59K – 5314
2016
Q1 		$59K Sell
432
-1,362
-76% -$179K ﹤0.01% 3741
2015
Q4 		$249K Buy
+1,794
New +$249K ﹤0.01% 2499
2015
Q3 		– Sell
-100
Closed -$15K – 4958
2015
Q2 		$15K Buy
+100
New +$14.3K ﹤0.01% 4122

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Walleye Trading's BIO Position: Q4 2022 in Review

Walleye Trading sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2022, closing a stake of 918 shares — an estimated $383K sold.

Walleye Trading first reported a position in BIO in Q2 2015 and held it in 14 quarters. The position peaked at $592K in Q4 2021. 470 funds tracked by Wall St. Rank hold BIO as of Q4 2022.

  • Walleye Trading reported no remaining Bio-Rad Laboratories Class A position as of Q4 2022 after selling out during the quarter.
  • Walleye Trading sold 918 Bio-Rad Laboratories Class A shares in Q4 2022, an estimated $383K.
  • Walleye Trading first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and held it in 14 quarters.
  • Walleye Trading's Bio-Rad Laboratories Class A position peaked at $592K in Q4 2021.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.